Sweetch is an Artificial Intelligence based platform for large scale prediction, prevention and outcome improvement of chronic diseases - diabetes, hypertension, hyperlipidemia, and obesity. They believe that every individual should live a healthier lifestyle. Currently, no scalable and cost-effective solution exists that helps the prediabetic population, therefore providing some sort of guidance is vital. Sweetch reduces the risk of diabetes and improves outcomes of chronic diseases by implementing a personalized intervention that focuses on emotional support and motivation to drive behavior change.
Sweetch is a game-changing platform that predicts personal diabetes risk and drives long-term behavioral change to prevent diabetes in a way never seen before. Sweetch was developed as a platform for any large-scale clinical outcome prediction, and personalized, data-driven, wellness prevention intervention in the most cost-effective patients. Diabetes is our first use case.
B2C, B2B
1 to 25
Series A
$15,532,000
Scaling Up
2013
Managed Health Care
Healthcare
Health Care Facilities & Hospitals
N/A
Increase Efficiency
Analytics
IT and Security
Service
Yes
Active
Machine Learning
Natural Language Processing
N/A
Software
7
1
$20M
Company was founded 2013 and it took almost 8 years (Jul 2021) to raise first external round
Investors
Interested in researching Sweetch?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Sweetch
Potential Customers
Interested in what they do or partnership?
Learn more about how they work